[Management of decompensated liver cirrhosis in the intensive care unit]

O Lerschmacher1, A Koch, K Streetz

  • 1Medizinische Klinik III, Universitätsklinikum RWTH-Aachen, Pauwelsstr. 30, 52074, Aachen, Deutschland.

Insights

Optimal intensive care unit (ICU) management improves prognosis for patients with liver cirrhosis complications. Early diagnosis and treatment of acute variceal bleeding, spontaneous bacterial peritonitis, and hepatorenal syndrome are crucial for survival.

Area of Science:

  • Hepatology
  • Critical Care Medicine

Context:

  • Liver cirrhosis represents the advanced stage of chronic liver diseases.
  • Complications significantly elevate mortality risk in cirrhotic patients.
  • Effective management in the intensive care unit (ICU) can improve patient outcomes.

Purpose:

  • To outline diagnostic algorithms for identifying cirrhosis etiology and complications upon ICU admission.
  • To detail management strategies for critical complications of liver cirrhosis.

Summary:

  • Acute variceal bleeding necessitates endoscopic intervention, vasoactive drugs, antibiotics, and potentially transjugular intrahepatic portosystemic shunt (TIPS).
  • Spontaneous bacterial peritonitis requires prompt diagnosis and treatment in patients with ascites.
  • Hepatorenal syndrome management involves albumin and terlipressin.
  • Respiratory failure in cirrhosis demands a broad differential diagnosis including hepatic hydrothorax and portopulmonary hypertension.
  • Liver transplantation feasibility should be evaluated for decompensated cirrhosis patients, with artificial liver support as a temporary measure.

Impact:

  • Standardized diagnostic and management protocols can enhance survival rates for critically ill cirrhotic patients.
  • Improved recognition and treatment of specific complications can reduce ICU morbidity and mortality.
  • Timely consideration of liver transplantation offers a definitive treatment option for eligible patients.

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...